Diabetes and COVID-19: A Tale of 2 Pandemics
J Cardiovasc Pharmacol
.
2021 Jul 1;78(1):e1-e2.
doi: 10.1097/FJC.0000000000001047.
Authors
Ali A Rizvi
1
2
,
Andrei Janez
3
,
Wael Al Mahmeed
4
,
Manfredi Rizzo
2
5
Affiliations
1
Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA.
2
Division of Endocrinology, Diabetes and Metabolism University of South Carolina School of Medicine, Columbia, SC.
3
Department of Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Ljubljana, Slovenia.
4
Cardiology Unit, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates; and.
5
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Italy.
PMID:
34173808
PMCID:
PMC8253376
DOI:
10.1097/FJC.0000000000001047
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Diabetes Mellitus*
Humans
Pandemics
SARS-CoV-2